Richard King Mellon Foundation

Richard King Mellon Foundation

Richard King Mellon Foundation

Date Founded



BNY Mellon Center,500 Grant Street,Suite 4106,Pittsburgh, PA 15219-2502

Charitable Causes

Private Grantmaking Foundations


Social Interest
Investment Services & Portfolio Management

Company Description

Richard King Mellon Foundation is a grant making foundation. They focus on programs that prioritize conservation, regional economic development, education and human services in the pennsylvania area. The organization was founded in 1947 and is headquartered in Pittsburgh, PA.

Contact Data
Trying to get in touch with decision makers at Richard King Mellon Foundation? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman & Chief Executive Officer

President & Trustee

Senior Information & Grants Manager

Senior Program Officer



Investments & Tax

Senior Vice President & Chief Investment Officer


Board of Directors

Chairman & Chief Executive Officer at Richard King Mellon Foundation

Paths to Richard King Mellon Foundation
Potential Connections via
Relationship Science
Richard King Mellon Foundation
Recent Transactions
Details Hidden

purchases Progyny, Inc. from Richard King Mellon Foundation, Union Grove Partners Direct Venture Fund, L.P., Merck Ventures

Transaction Advisors
Legal Advisor

Advised on purchases Progyny, Inc. from Richard King Mellon Foundation, Union Grove Partners Direct Venture Fund, L.P., Merck Ventures

Advisors & Consultants
Investment Manager

OCM specializes in alternative investments that inves tin closed-end, open-end and evergreen vehicles across four asset classes: Credit, Private Equity, Real Assets, and Listed Equities. They uses fundamental bottom-up analysis and may engage in long term or short term purchases, trading, short sales in certain strategies, margin transactions, and option writing, including covered options, uncovered options or spreading strategies.

Investment Manager

BFM utilizes fixed-income strategies that are actively managed, model or index based. Actively managed fixed-income mandates generally employ an active investment style that emphasizes rotation among different types of debt on a relative value basis, specific security selection, quantitative analysis of each security and the portfolio as a whole and intensive credit analysis and review. They utilize a risk-controlled, systematic process for portfolio construction and alpha generation. Alpha sources may include security selection, duration and yield curve positioning, industry rotation, asset allocation, and currency positioning. BFM's equity platform includes a broad range of products that vary according to investment style (active, scientific and passive management), market-cap (small-, mid-, small/mid-, large- and all-cap), and geography (global, international and regional). The product range may also include sector funds, long-only and long-short portfolios, as well as products that combine different strategies to create balanced and asset allocation portfolios. For cash management portfolios, the investment process emphasizes safety and liquidity over yield. Their alternative mandates focus on sourcing and managing high-alpha investments with lower correlation to public markets and developing a holistic approach to address client needs in alternatives investing.

Investment Manager

MCM primarily uses top-down and bottom-up fundamental methods of analysis in implementing its strategies. While they invest primarily in growth equity securities for clients, client accounts also may hold a variety of other securities and investments potentially including fixed income if desired. The firm does not does not generally manage portfolios based on alternative strategies such as asset allocation, long-short, risk-neutral, absolute return, or similar strategies. MCM doesn’t use quantitative filters or screens or optimization techniques in portfolio construction, or target tracking error levels, standard deviations, or other such metrics.

Non-Profit Donations & Grants
Details Hidden

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. It focuses on its vonoprazan product, an oral small molecule potassium-competitive acid blocker. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Details Hidden

Nuvaira develops medical devices for treating lung diseases. It works on a novel catheter-based system that has the potential to improve lung function, exercise capacity and quality of life for patients with chronic obstructive pulmonary disease. The company was founded by Steven Dimmer and Martin L. Mayse in 2008 and is headquartered in Plymouth, MN.

Details Hidden

metavention, Inc. develops novel interventional therapies and sympathetic nervous system. The company was founded by Bobak Azamian in 2011 and is headquartered in Eden Prairie, MN.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Richard King Mellon Foundation. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Richard King Mellon Foundation's profile does not indicate a business or promotional relationship of any kind between RelSci and Richard King Mellon Foundation.